Table of Contents
Chapter 1. Global Drug Formulation Market Executive Summary
1.1. Global Drug Formulation Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Dosage Form
1.3.2. By Indication
1.3.3. By End User
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Drug Formulation Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer's Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Drug Formulation Market Dynamics
3.1. Market Drivers
3.1.1. Rising prevalence of chronic diseases
3.1.2. Technological advancements in drug formulation
3.1.3. Increasing investment in pharmaceutical R&D
3.2. Market Challenges
3.2.1. Complexity of supply chains
3.2.2. Patent cliffs and shortened patent life
3.2.3. Increasing generic competition
3.3. Market Opportunities
3.3.1. Growth in personalized medicine
3.3.2. Expansion in emerging markets
3.3.3. Advances in biotechnology
Chapter 4. Global Drug Formulation Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model
4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Drug Formulation Market Size & Forecasts by Dosage Form 2022-2032
5.1. Segment Dashboard
5.2. Global Drug Formulation Market: Dosage Form Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Oral formulations
5.2.2. Parenteral formulations
5.2.3. Topical formulations
5.2.4. Inhalation formulations
Chapter 6. Global Drug Formulation Market Size & Forecasts by Indication 2022-2032
6.1. Segment Dashboard
6.2. Global Drug Formulation Market: Indication Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. Infectious Diseases
6.2.2. Cancer
6.2.3. Cardiovascular Diseases
6.2.4. Diabetes
6.2.5. Respiratory Diseases
6.2.6. Central Nervous System Disorders
6.2.7. Autoimmune Diseases
6.2.8. Gastrointestinal Diseases
6.2.9. Musculoskeletal Disorders
6.2.10. Dermatological Disorders
6.2.11. Other
Chapter 7. Global Drug Formulation Market Size & Forecasts by End User 2022-2032
7.1. Segment Dashboard
7.2. Global Drug Formulation Market: End User Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. Big pharma
7.2.2. Small & Medium Size Pharma
7.2.3. Biotech Companies
Chapter 8. Global Drug Formulation Market Size & Forecasts by Region 2022-2032
8.1. North America Drug Formulation Market
8.1.1. U.S. Drug Formulation Market
8.1.1.1. Dosage Form breakdown size & forecasts, 2022-2032
8.1.1.2. Indication breakdown size & forecasts, 2022-2032
8.1.1.3. End User breakdown size & forecasts, 2022-2032
8.1.2. Canada Drug Formulation Market
8.2. Europe Drug Formulation Market
8.2.1. U.K. Drug Formulation Market
8.2.2. Germany Drug Formulation Market
8.2.3. France Drug Formulation Market
8.2.4. Spain Drug Formulation Market
8.2.5. Italy Drug Formulation Market
8.2.6. Rest of Europe Drug Formulation Market
8.3. Asia-Pacific Drug Formulation Market
8.3.1. China Drug Formulation Market
8.3.2. India Drug Formulation Market
8.3.3. Japan Drug Formulation Market
8.3.4. Australia Drug Formulation Market
8.3.5. South Korea Drug Formulation Market
8.3.6. Rest of Asia Pacific Drug Formulation Market
8.4. Latin America Drug Formulation Market
8.4.1. Brazil Drug Formulation Market
8.4.2. Mexico Drug Formulation Market
8.4.3. Rest of Latin America Drug Formulation Market
8.5. Middle East & Africa Drug Formulation Market
8.5.1. Saudi Arabia Drug Formulation Market
8.5.2. South Africa Drug Formulation Market
8.5.3. Rest of Middle East & Africa Drug Formulation Market
Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. AstraZeneca plc.
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Market Strategies
9.3.2. Bristol-Myers Squibb
9.3.3. Eli Lilly and Company
9.3.4. Gilead Sciences, Inc.
9.3.5. Merck & Co., Inc.
9.3.6. Novartis AG
9.3.7. Pfizer Inc.
9.3.8. AbbVie Inc.
9.3.9. Boehringer Ingelheim International GmbH
9.3.10. F. Hoffmann-La Roche AG
9.3.11. Johnson & Johnson
9.3.12. 3M Company
9.3.13. Bayer AG
9.3.14. Teva Pharmaceuticals Industries Ltd.
9.3.15. Amgen, Inc.
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes